http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104225685-B

Outgoing Links

Predicate Object
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/D04H1-541
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/D04H1-728
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/D01D5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-54
filingDate 2014-09-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2016-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2016-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-104225685-B
titleOfInvention A kind of preparation method conducting electricity spacetabs type neural tissue engineering support
abstract The present invention relates to a kind of preparation method conducting electricity spacetabs type neural tissue engineering support, including: fibroin albumen Silk and lactic acid caprolactone copolymer are dissolved in solvent, dissolve stirring, obtain solution, it is subsequently adding polyaniline PANi and camphorsulfonic acid, stirs and evenly mixs, obtain cortex electrostatic spinning solution;Nerve growth factor is dissolved completely in ultra-pure water, obtains sandwich layer electrostatic spinning solution;Cortex electrostatic spinning solution, sandwich layer electrostatic spinning solution are respectively charged in syringe, carry out coaxial electrostatic spinning, then suffocating treatment, vacuum drying, obtain conductivity type neural tissue engineering support.The approach such as the nano fiber scaffold that the present invention prepares topological structure orientation guide needed for additional electro photoluminescence conducting polymer, biochemistry nerve growth factor and nerve regneration promote CO2 laser weld speed.The inventive method is simple to operate, favorable repeatability, high financial profit, and the neurologic defect reparation for running in clinic provides new experimental considerations.
priorityDate 2014-09-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID18049
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID310738
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID281350
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID403402
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419522329
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP34129
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419562219
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP21617
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID469423
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID4803
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18462
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID108709389
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ6YBR5
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID396466
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13529

Total number of triples: 33.